Use of an Online Intervention for the Treatment of Diabetes Distress in Patients With Type 1-Diabetes
NCT06436456
Summary
This study will investigate whether an online intervention can be helpful in reducing diabetes distress in people with type 1 diabetes and elevated diabetes distress, compared to individual counselling sessions (online, phone-based or face-to-face, depending on the preference of the person with type 1 diabetes). Half of the participants will receive the online intervention, while the other half will receive individual counseling sessions with a psychologist. Objectives: The main aim of this study is to investigate if the online intervention is feasible and liked by people with type 1 diabetes and diabetes distress, in comparison with individual counselling sessions. Hypotheses: The investigators predict that both interventions will be feasible to use, shown by how many people join, stay engaged, and complete the interventions. The investigators also think that people will find both interventions acceptable, as shown by the positive feedback given in interviews after they finish.
Eligibility
Inclusion Criteria: * A total score or a score on one of the subscales of the Diabetes Distress Scale for type 1 diabetes which is 2 or above. * Diagnosed with type 1-diabetes ≥ 12 months ago. * Age ≥ 30 years. * Receiving treatment at SDCO. * Proficiency in Danish and basic IT skills. Exclusion Criteria: * Psychiatric diagnosis that may compromise participation in the intervention e.g. psychosis, schizophrenia, substance or alcohol abuse. * Cognitive impairments that may compromise participation in the intervention e.g. dementia, Alzheimer's, brain injury. * Complex issues best suited for individual treatment as assessed by the clinical psychologist.
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06436456